People
Filter News
Found 62,665 articles
-
Form Bio Establishes Scientific Advisory Board, Comprised of Renowned Experts in Cell and Gene Therapy, for Advancing AI-Driven Therapies
4/18/2024
Form Bio today announced the creation of a new Scientific Advisory Board (SAB).
-
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
4/18/2024
Anixa Biosciences, Inc today announced the appointment of Sanjay Juneja, MD to its Cancer Business Advisory Board.
-
BiomX Announces the Appointment of Susan Blum to its Board of Directors
4/18/2024
BiomX Inc. today announced the appointment of Susan Blum to its Board of Directors.
-
NeoGenomics Announces Senior Leadership Promotions
4/18/2024
NeoGenomics, Inc. today announced two promotions within its senior leadership team, effective immediately.
-
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer
4/18/2024
deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen identification for sepsis and other acute infections, announces the appointments of Dr Kimberle Chapin as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer.
-
Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
4/18/2024
Biophytis SA announces the formation of a new Scientific Advisory Board to support the advancement of its phase 2 OBA clinical study in obesity.
-
Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer
4/18/2024
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of John Hayslip, M.D., an accomplished oncologist with deep clinical research, development, and commercialization experience, to chief medical officer where he will lead the Company’s clinical and medical strategy.
-
Read the latest overview of people coming and going from executive positions at biopharma companies covered by BioSpace.
-
National Comprehensive Cancer Network Awards Champions for Excellence and Outstanding Contributions in Cancer Care
4/17/2024
The National Comprehensive Cancer Network® is announcing 2024 award recipients that include individuals and groups who have made significant and noteworthy impacts on improving cancer care and supporting NCCN's mission to help all people with cancer to live better lives.
-
Accuryn Medical Announces Leadership Transition
4/17/2024
Accuryn Medical, innovator of the Accuryn Monitoring System, a device designed to monitor the kidney, reduce the risks associated with catheter-associated urinary tract infections and streamline nurse workflow, announced a significant leadership transition.
-
Darcy Birse Named CEO of Culture Biosciences, Leading the Company into Its Next Phase of Growth
4/17/2024
Culture Biosciences is proud to announce the appointment of Darcy Birse as its new Chief Executive Officer.
-
Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer
4/17/2024
Domain Therapeutics today announces the appointment of Sean A. MacDonald as its Chief Executive Officer (CEO).
-
PharmaCord Announces Leadership Expansion, Appointing Rob Brown to Chief Growth Officer
4/17/2024
PharmaCord LLC, a leading provider of patient support services for the pharmaceutical industry, is pleased to announce the appointment of Rob Brown as Chief Growth Officer.
-
Lipella Pharmaceuticals Expands its Advisory Board
4/17/2024
Lipella Pharmaceuticals Inc. today announced the expansion of its Scientific Advisory Board to include oncology expertise.
-
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
4/17/2024
Stoke Therapeutics, Inc. today announced the appointment of Jason Hoitt as Chief Commercial Officer.
-
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
4/17/2024
Serina Therapeutics, Inc., a clinical-stage biotechnology company focused on developing its proprietary POZ PlatformTM drug delivery technology announced the appointment of Dr. Simba Gill as Executive Chairman.
-
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer
4/17/2024
Sensorium Therapeutics today announced the appointment of Sam Rasty, Ph.D., as Chief Business Officer.
-
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
4/17/2024
89bio, Inc. announced the appointment of Martin Babler to its Board of Directors, effective April 13, 2024.
-
Evotec welcomes Aurélie Dalbiez as Chief People Officer
4/17/2024
Evotec SE announced the appointment of Aurélie Dalbiez as the Company's new Chief People Officer, effective 15 June 2024.
-
Jacques Banchereau, PhD Appointed as Chief Scientific Officer at Javelin Biotech
4/17/2024
Javelin Biotech, Inc., a leading technology company specializing in human tissue chip platforms for biopharma research, is delighted to announce the appointment of Jacques Banchereau, PhD as its Chief Scientific Officer (CSO).